日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Activation of AMP-activated Protein Kinase by Metformin Inhibits Dedifferentiation of Platelet-derived Growth Factor-BB-induced Vascular Smooth Muscle Cells to Improve Arterial Remodeling in Cirrhotic Portal Hypertension.

二甲双胍激活 AMP 激活蛋白激酶抑制血小板衍生生长因子-BB 诱导的血管平滑肌细胞去分化,从而改善肝硬化门静脉高压的动脉重塑

Wu Guangbo, Fan Qiang, Chen Min, Luo Guqing, Wu Zhenghao, Zhao Jinbo, Lin Jiayun, Zhang Chihao, Li Hongjie, Qi Xiaoliang, Huo Haizhong, Zheng Lei, Luo Meng

Therapeutic potential of formononetin in cirrhotic portal hypertension: modulating hepatic fibrosis, macrophage polarization, and lymphangiogenesis.

芒柄花素在肝硬化门静脉高压症中的治疗潜力:调节肝纤维化、巨噬细胞极化和淋巴管生成

Wu Zhenghao, Luo Guqing, Li Hongjie, Chen Min, Wu Guangbo, Fan Qiang, Zhang Chihao, Yu Jiwei, Lin Jiayun, Zhao Jinbo, Qi Xiaoliang, Huo Haizhong, Luo Meng, Zheng Lei

A novel noninvasive assessment of portal pressure from computational biofluid mechanics in patients with portal hypertension

一种利用计算生物流体力学对门静脉高压患者门静脉压力进行无创评估的新型方法

Zheng, Lei; Wu, Guangbo; Lin, Jiayun; Li, Hongjie; Zhang, Chihao; Zhao, Zhifeng; Chen, Min; Wu, Zhenghao; Luo, Guqing; Fan, Qiang; Qi, Xiaoliang; Huo, Haizhong; Sun, Longci; Luo, Meng